国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2010年
9期
646-648
,共3页
肿瘤干细胞%条件增殖腺病毒%基因治疗
腫瘤榦細胞%條件增殖腺病毒%基因治療
종류간세포%조건증식선병독%기인치료
Neoplastic stem cells%Conditionally replicative adenoviruses%Gene therapy
肿瘤干细胞(CSC)具有自我更新及分化潜能,是肿瘤生长和转移的源泉,与化放疗抵抗密切相关,能否彻底根除CSC决定肿瘤治疗的成败.条件增殖腺病毒(CRAd)是一类仅在肿瘤细胞内特异增殖的新型病毒载体,可同时靶向肿瘤细胞和肿瘤干细胞,为彻底治愈肿瘤带来曙光.
腫瘤榦細胞(CSC)具有自我更新及分化潛能,是腫瘤生長和轉移的源泉,與化放療牴抗密切相關,能否徹底根除CSC決定腫瘤治療的成敗.條件增殖腺病毒(CRAd)是一類僅在腫瘤細胞內特異增殖的新型病毒載體,可同時靶嚮腫瘤細胞和腫瘤榦細胞,為徹底治愈腫瘤帶來曙光.
종류간세포(CSC)구유자아경신급분화잠능,시종류생장화전이적원천,여화방료저항밀절상관,능부철저근제CSC결정종류치료적성패.조건증식선병독(CRAd)시일류부재종류세포내특이증식적신형병독재체,가동시파향종류세포화종류간세포,위철저치유종류대래서광.
Cancer stem cells (CSC) are capable of self-renewal and differentiation, properties that are critical to tumor growth, metastasis, and radioresistance. Eradication of CSC is the key to the success of cancer therapy. Conditionally replicative adenoviruses(CRAd) are a novel class of viral agents which selectively replicate in tumor cells but not in normal cells. CRAd can specifically target and eradicate CSC ,representing a promising cure for cancer.